Keranova, a French surgical ophthalmology equipment developer, has received 24 million euros ($27 million) in its second funding round.

Keranova secured the new capital from current shareholders, Mérieux Equity Partners and Supernova Invest, as well as Financière Arbevel, Tourrette Investissement and other global partners.

The startup is planning to leverage the proceeds from the new investment to speed up the development of its technologies.

Keranova will also use the new funds to obtain the regulatory authorizations needed to market its solution for precise, repeatable and automated robotized procedures for cataract surgery.